The burgeoning landscape of therapy for obesity and type 2 metabolic disorder is currently witnessing considerable excitement surrounding both retatrutide and tirzepatide. While both represent novel dual GIP and GLP-1 https://saulecbp014701.uzblog.net/retatrutide-vs-tirzepatide-a-comparative-analysis-52455197